Resolvyx Pharmaceuticals
Resolvyx Pharmaceuticals develops therapeutics with small molecule lipid mediators for the treatment of inflammatory diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$125m (Public information from Nov 2010)
Cambridge Massachusetts (HQ)
Authorizing premium user...